CytoDyn (OTCQB:CYDY) announces that the Republic of the Philippines, Department of Health, Food and Drug Administration has approved the use of leronlimab to treat a COVID-19 patient under Compassionate Special Permit (CSP) pursuant to FDA Order No. 2016-005.